Forum Replies Created

Viewing 15 posts - 271 through 285 (of 317 total)
  • Author
    Posts
  • in reply to: Another Generic Pharma Co In Bangladesh #1664
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Sir, wot r u like? :P The original post has been deleted from where I found it, But the pharma co is:

    http://www.beaconpharma.com.bd

    I remember the prices were 6US$ per pill of Sof and 3.8US$ per pill of Dac, including shipment.

    I expect contact can be made via their website.

    in reply to: Nadia’s journey #1660
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Ah, ok. Thanks for the clarification. I suppose that’s one of the risks of being in a trial. Hopefully, your friend won’t have developed a ns5a resistance from the failed experiment.

    in reply to: Nadia’s journey #1653
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    I’ve found and attached the EASL 2014 report. If your friend was treated on a 12 week therapy after the report came out, he should give that clinic a very wide berth.

    in reply to: Nadia’s journey #1650
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad
    david wrote:

    i had the same conversation with someone else .i thought 24 weeks is best but the other guy said there is no advantage in doing 24.if you are going to clear 12 will do it.all i know is that my friend did 12 and didnt clear.

    That was probably me. Just to make clear: 12 weeks Sof/Dac is for non-cirrhotic/non-borderline G3’s.

    in reply to: Nadia’s journey #1649
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad
    david wrote:

    i have a friend on an NHS trial in Wales that did 12 weeks sof/dac for gt3,prior non responder and cirrhosis.He relapsed 12 weeks after tx and now has to do 24 weeks sof/dac/riba.unfortunately I think interferon combo with sof/riba is still the best for g3.Not certain about this as things are moving so fast..

    Maybe they didn’t know back then what they know now (we’d have to find an older EASL report to find out), but the EASL standard for G3 cirrhotics is 24 weeks Sof/Dac/Riba. The treatment using interferon is sub-optimal, and only used because it’s cheaper.

    in reply to: Nadia’s journey #1643
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    There’s also the latest EASL report, which is available in various threads on here.

    in reply to: Nadia’s journey #1640
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    And your old consultant would be wrong Nadia:

    http://hcvsvrpredictor.liverdoc.com/#/

    My old consultant also said the same to me. And the average Joe/Joanne Hepper will believe them. If they could find it in themselves to be honest with us, they would tell us that it’s the cheapest treatment for G3 using new meds.

    in reply to: Nadia’s journey #1612
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Well, considering that most of the treatments available here in the UK are somewhat akin to cavemen clubbing the virus out of you (interferon/riba), they can talk :P

    in reply to: Nadia’s journey #1602
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Yes, I put them in my blog thread “Gamma GT”. They’re in one of my latest posts there.

    in reply to: Nadia’s journey #1600
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    I’m also in the UK. Same genotype. 4-and-a-bit weeks into the same combination therapy, except my generic Sov is Hetero’s Sofovir. It’ll be great to compare and contrast our experiences travelling down the same road. All the best Nadia.

    in reply to: Interesting ppt about cost of hep c drugs #1596
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Every public health administrator in the world should be made to read and re-read this until they understand it, then their big boss should be made to appear on national tv to justify why they aren’t already implementing it.

    in reply to: Would you like to be part of a social movement? #1525
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    I’m prepared to set up/help set up a UK forum Doc. But I’d need techie help with software maintenance/security, which.is something I know almost nothing about.

    in reply to: Hep C 3 treatment #1517
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Hi Vicki,

    The 2015 EASL report is widely considered to be a benchmark document on treatment types. I’m pretty sure it’s available elsewhere on this forum, but I’ve attached it to this post.

    in reply to: where can i get a prescription in the uk? #1516
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    I’d be surprised if blood tests from June were unacceptable to the Pall Mall Consultant, Wiko, unless your health has taken a noticable turn for the worse since then. When I saw him for the first time at the end of July, he didn’t have a problem with my viral load test which had been done in April.

    in reply to: Gamma GT #1484
    Avatar photoAlsdad
    • Guardian Angel
    • ★★★★★
    @alsdad

    Got my case file in the post this morning that I’d requested under Freedom of Information Laws.

    Most of it is run-of-the-mill back and forth between doctors and sume semi-related investigations by the Rheumatology Dept (who I got my viral load result from during an appiontment in June !?!?!).

    I’ve attached a letter sent from the Hepatology Clinic to my GP Practice which I hadn’t seen before. It shows just what we’re up against in our attempts to get some kind of co-operation from the NHS.

    btw It wasn’t me suggesting 20 weeks of Sof/Riba therapy (my first medicine choice before the Mesochem Dac became available), I told my GP 24 weeks, and she got it wrong, but I’ll forgive her that because she’s doing my basic blood tests now.

    The clinic also spelled my name wrong :lol: but you can’t see that because I’ve redacted it.

Viewing 15 posts - 271 through 285 (of 317 total)